The International Council on Infertility Information Dissemination, Inc

NOVARELTM HCG ADDED TO FERRING INFERTILITY LINE

A Ferring Pharmaceuticals News Release

Contact: Laura Moulder

(203) 762-8833


 

NOVARELTM HCG ADDED TO FERRING INFERTILITY LINE

 

TARRYTOWN, NY – Ferring Pharmaceuticals broadens its line of infertility products with the addition of Novarelä (Chorionic Gonadotropin for Injection, USP). Designed to mimic the action of pituitary luteinizing hormone (LH), Novarel is used during ovulation induction therapy to trigger egg release. It can also be used in men to stimulate testosterone production.

 

"The introduction of Novarel is part of our ongoing commitment to provide therapeutically equivalent, cost-effective treatment alternatives to the reproductive community and their patients," says Wayne Anderson, president, Ferring Pharmaceuticals.

 

Novarel is available by prescription in 10 mL multiple dose vials containing 10,000 USP units with accompanying diluent.

 

For more information about Novarel, and/or infertility and its treatment, contact Ferring Pharmaceuticals at 888/337-7464.

 

# # #

Add new comment

(If you're a human, don't change the following field)
Your first name.
(If you're a human, don't change the following field)
Your first name.
(If you're a human, don't change the following field)
Your first name.
To prevent automated spam submissions leave this field empty.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.